ALHC · Alignment Healthcare, Inc.
$8.16
+0.25 (+3.16%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.64B
Shares
207.44M
Volume · Sep 30
8.79M
Avg daily vol (3M)
7.14M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.16
Open$7.92
Day$7.77–8.18
52W close$7.67–24.56
Avg vol 30d9.0M
Short int24.6M · 11.9% float · 3.5d
Short vol43%
Last earningsJul 30, 2026
DataMar 2021–Sep 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 30, 2026
Est · unconfirmed
· in 4 wks
filed Jul 30, 2026
call held Jul 30, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$4.58B
Trailing 12 months
Net income (TTM)
$40.70M
Trailing 12 months
Revenue growth YoY
+31.6%
Year over year
Operating margin
1.2%
Trailing 12 months
P / E (TTM)
39.6
Trailing earnings · reciprocal yield 2.5%
FCF yield
10.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$377.65M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.6%
Year over year · more shares
Price change (1Y)
-54.7%
Trailing year
Short interest
11.9%
Latest settlement · 3.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−55%
below
Price vs 50-day avg
−37%
below
RSI (14)
25
oversold
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−40%
trailing
6-month return
−62%
trailing
YTD return
−59%
this year
Relative strength
−74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $13 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+12% holders QoQ · +82 funds added
Insider flow
Distributing
Net -$1.8M over 90 days · 100% sells
Short interest
Rising
11.87% of float · ▲ +7.8% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
330 holders — near 3-yr high, broad support
Squeeze score
57
elevated · 0–100
Fundamentals
Revenue growth
+46%
Y/Y
EPS growth
+100%
Y/Y
Free cash flow
$113.1M
Balance sheet
$252.6M
net cash
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−69%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
Adjusted EBITDA
· Twelve Months Ending December 31, 2026
Non-GAAP
Initiated
$145M – $163M
Guided vs delivered
· last 4 settled
Revenue
fourth quarter of 2021
guided $265M – $270M
$298.27M
Beat +11.5%
Revenue
full year 2021
guided $1.14B – $1.14B
$1.17B
Beat +2.7%
Revenue
third quarter of 2021
guided $270M – $275M
$293.47M
Beat +7.7%
Revenue
second quarter of 2021
guided $265M – $270M
$308.95M
Beat +15.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−55%
Bearish
Price vs 50-day avg
−37%
Bearish
RSI (14)
25
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $13 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+12% holders QoQ · +82 funds added
Insider flow
Distributing
Net -$1.8M over 90 days · 100% sells
Short interest
Rising
11.87% of float · ▲ +7.8% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
330 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $8
Now $8 · 3%
Range high $25
vs 200-day avg -55%
vs 50-day avg -37%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALHC
this stock
Alignment Healthcare, Inc.
|
$1.64B | -58.7% | +46.1% | — | 11.9% |
|
UNH
Unitedhealth Group Inc
|
$338.03B | +11.2% | +11.8% | — | 1.5% |
|
CVS
CVS HEALTH Corp
|
$110.82B | +8.0% | +7.8% | 22.9 | 1.3% |
|
ELV
Elevance Health, Inc.
|
$85.90B | +10.9% | +12.5% | 17.5 | 2.5% |
|
CI
Cigna Group
|
$71.06B | -1.2% | +11.2% | 11.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALHC | +3.8% | -40.0% | -61.8% | -39.1% | -58.7% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +4.5% | -40.1% | -74.0% | -38.5% | -70.5% |
Key facts
CIK
1832466
CUSIP
01625V104
13F (30d)
13 filings
9 filers
Visit website
Investor relations